tiprankstipranks
Trending News
More News >
Sirnaomics Ltd. (HK:2257)
:2257
Hong Kong Market
Advertisement

Sirnaomics Ltd. (2257) Price & Analysis

Compare
4 Followers

2257 Stock Chart & Stats


Sirnaomics Ltd. News

2257 FAQ

What was Sirnaomics Ltd.’s price range in the past 12 months?
Sirnaomics Ltd. lowest stock price was HK$2.35 and its highest was HK$22.78 in the past 12 months.
    What is Sirnaomics Ltd.’s market cap?
    Sirnaomics Ltd.’s market cap is HK$1.76B.
      When is Sirnaomics Ltd.’s upcoming earnings report date?
      Sirnaomics Ltd.’s upcoming earnings report date is Mar 26, 2026 which is in 187 days.
        How were Sirnaomics Ltd.’s earnings last quarter?
        Sirnaomics Ltd. released its earnings results on Aug 28, 2025. The company reported -HK$0.312 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.312.
          Is Sirnaomics Ltd. overvalued?
          According to Wall Street analysts Sirnaomics Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Sirnaomics Ltd. pay dividends?
            Sirnaomics Ltd. does not currently pay dividends.
            What is Sirnaomics Ltd.’s EPS estimate?
            Sirnaomics Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Sirnaomics Ltd. have?
            Sirnaomics Ltd. has 105,166,176 shares outstanding.
              What happened to Sirnaomics Ltd.’s price movement after its last earnings report?
              Sirnaomics Ltd. reported an EPS of -HK$0.312 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -8.205%.
                Which hedge fund is a major shareholder of Sirnaomics Ltd.?
                Currently, no hedge funds are holding shares in HK:2257

                Sirnaomics Ltd. Stock Smart Score

                Company Description

                Sirnaomics Ltd.

                Sirnaomics Ltd. (2257) is a biopharmaceutical company that focuses on discovering and developing RNAi-based therapeutics. The company is engaged in the research and development of innovative treatments for diseases with high unmet medical needs, including cancer, fibrosis, and viral infections. Sirnaomics leverages its proprietary technology platforms to design and optimize small interfering RNA (siRNA) molecules that target specific genes involved in disease processes.

                Sirnaomics Ltd. (2257) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                TOT BIOPHARM International Co. Ltd.
                Clover Biopharmaceuticals Ltd.
                CStone Pharmaceuticals
                SinoMab Bioscience Ltd.
                Transcenta Holding Limited

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis